Published online Jun 27, 2022. doi: 10.4240/wjgs.v14.i6.556
Peer-review started: July 28, 2021
First decision: September 5, 2021
Revised: September 24, 2021
Accepted: June 17, 2022
Article in press: June 17, 2022
Published online: June 27, 2022
Processing time: 334 Days and 3.2 Hours
Closed-loop small bowel obstruction (CL-SBO) can threaten the viability of the intestine by obstruction of a bowel segment at two adjacent points. Prompt recognition of CL-SBO, followed by surgery, is crucial. Clinical predictors of perioperative ischemia and postoperative outcome have not been previously analyzed in a cohort as large as this one.
To date, most studies have evaluated patients with SBOs by comparing surgical vs conservative treatments. Studies for CL-SBOs have mostly focused on aspects of computed tomography imaging. The perioperative findings of previous studies vary and there is often a lack information on the postoperative outcomes.
The aim of this study was to analyze perioperative characteristics and postoperative outcomes of patients with surgery for CL-SBO and to evaluate clinical predictors.
The medical records of a cohort of 148 patients who underwent surgery for CL-SBO were analyzed retrospectively. Univariate analysis was performed to identify clinical characteristics that were associated with specific perioperative outcomes. The odds ratios for those that were significantly associated with outcomes were analyzed by logistic regression.
Of 148 patients with CL-SBO, 28 (19%) had a perioperative viable small bowel, 86 (58%) had reversible ischemia and 34 (23%) had irreversible ischemia. Median age and American Society of Anesthesiologists (ASA) classification were significantly higher in patients with irreversible ischemia (P = 0.042 and 0.008, respectively). Postoperative morbidity was significantly higher in patients with perioperative irreversible ischemia (45%, P = 0.043) than in those with reversible ischemia (20%) and a viable bowel (4%).
Older patients and those with an ASA classification ≥ 3 had an increased risk of irreversible ischemia. C-reactive protein within the normal range did not ensure the absence of ischemia. After irreversible ischemia, postoperative morbidity was increased.
The study results are relevant to preoperative informed consent procedures in patients with CL-SBO. Close attention should be paid to patients with perioperative ischemia for the prompt detection of postoperative complications.